Our results suggest that the contributions of IL-1 to AD pathology include influences of this cytokine on synaptic function [33]; namely, (i) a decrease in synaptophysin, perhaps indicative of inflammation-related synapse loss, and (ii) an increase in α-synuclein, perhaps in an attempt to repair this very event [34]. The gene discussed is IL1B; the disease is Alzheimer disease.